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Abstract: In order to calculate the dose for nanoparticles (NP), (i) relevant information 
about the dose metrics and (ii) a proper dose concept are crucial. Since the appropriate 
metrics for NP toxicity are yet to be elaborated, a general dose calculation model for 
nanomaterials is not available. Here we propose how to develop a dose assessment model 
for NP in analogy to the radiation protection dose calculation, introducing the so-called 
“deposited and the equivalent dose”. As a dose metric we propose the total deposited NP 
surface area (SA), which has been shown frequently to determine toxicological responses 
e.g. of lung tissue. The deposited NP dose is proportional to the total surface area of 
deposited NP per tissue mass, and takes into account primary and agglomerated NP.  
By using several weighting factors the equivalent dose additionally takes into account 
various physico-chemical properties of the NP which are influencing the biological 
responses. These weighting factors consider the specific surface area, the surface textures, 
the zeta-potential as a measure for surface charge, the particle morphology such as the 
shape and the length-to-diameter ratio (aspect ratio), the band gap energy levels of metal 
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and metal oxide NP, and the particle dissolution rate. Furthermore, we discuss how these 
weighting factors influence the equivalent dose of the deposited NP.  
Keywords: nanotoxicology; radiation biology; deposited nanoparticle dose; dose rate; 
equivalent dose; effective dose; nanoparticle surface area 
 
1. Introduction 
It has been estimated that the number, variety, and assortment of applications of engineered 
nanoparticles (NPs) will increase rapidly over the next few years [1]. Due to their intrinsic properties, 
NPs are commonly used in a variety of areas, not only in electronics, photovoltaics, catalysis, 
engineering, cosmetics but also in medicine and pharmacy. Studies have shown evident toxicity of 
some NPs to living systems but because of the lack of knowledge of all the relevant toxicological 
mechanisms, a comprehensive risk assessment cannot be performed yet. There is a need for using 
novel and fast techniques such as high-throughput methods to test the potential toxicity of these 
materials. However, at this time tests are very expensive and time consuming [1]. Regulatory agencies, 
however, must be able to act also in the absence of complete toxicological data sets of NP effects. 
Therefore, appropriate NP dose model(s) have to be identified to facilitate dose assessment.  
There are different drivers of toxicological studies: the intrinsic chemical, the material morphology, 
and the radiation driven toxicity, which all use clearly defined metrics. It has been proposed that  
in nanotoxicology the total surface area of the NP and the NP surface reactivity are relevant dose 
metrics for toxicity. It is known that nanomaterials can induce significant toxic effects due to their 
physico-chemical properties. These include the surface of the material which can be involved in 
catalytic and oxidative reactions that may subsequently induce cytotoxicity [2], but there are also other 
properties, such as the NP shape, charge, etc. which influence the biological effects of NPs. 
Frequently, the observed toxicity was reported to be greater for nanoscale materials than that of bulk 
forms of the same material, which may be caused e.g., by their much larger specific surface area 
(SSA), i.e., surface area-to-volume ratio. Here we suggest a NP-dose model which considers the total 
deposited NP surface area (SA) per tissue mass.  
In the human body, three main portals of entry for nanomaterials are usually considered: the 
respiratory, the digestive, and the cutaneous (skin). The fourth portal of entry, direct NP injections into 
blood circulation in nanomedicinal applications, is not considered in the present paper. It has been 
shown in inhalation studies [3,4], that the majority (>90%) of deposited NPs in the alveolar region of 
the lungs is retained and gradually translocated into the circulation and subsequently accumulated in 
other organs/tissues of the body. In fact, this pathway of exposure has been studied more intensely than 
the other pathways. Regarding the uptake of NPs through the gastrointestinal tract, the number of 
available studies is relatively modest although the oral uptake of NPs, e.g. as supplements in food has 
increased steadily over the last decades. However, Bergin and Witzmann summarized in a recent 
review, that it is unlikely to have any toxic effects at typical levels of exposure via ingestion of  
NPs [5]. Current evidence for the uptake of NPs through the skin is very low and, therefore, we do not  
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include this pathway into our considerations. Thus, here we only focus on the deposited dose of NPs 
after inhalation. 
As already mentioned, the toxicity of nanomaterials is dependent on their physico-chemical 
properties. There are mathematical tools available, such as Quantitative Structure Activity Relationship 
(QSAR) models, which attempt to predict the potential NP toxicity depending on the physico-chemical 
characteristics of the material. QSAR also maximizes the understanding from existing experimental data 
to enable predictions for additional compounds that have not been tested [6]. Burello and  
co-workers [7–12], but also Nel and his group [13,14], discussed several applications of QSAR for 
nanomaterials. However, the application of nano-QSAR is still limited because of the complexity and 
potential “unknowns” of the nanomaterials (relating to properties, interferences with environmental 
and biological matrices, dynamic changes etc.) [10]. Puzyn et al. [15] have shown by using the QSAR 
concept and Escherichia coli as the test model, that QSAR is a partly applicable model for predictive 
toxicity of a small set of nanosized metal oxides. Gajewicz et al. [16] reviewed the state of the art of 
the different predictive computational approaches and recommended a cooperative approach between 
computational scientists and toxicologists with a view to develop predictive toxicology for NPs  
in order to design safe nanoproducts. A recent review [17] listing major knowledge gaps suggested an 
increased use of QSAR methods to predict NP toxicity. However, it is not clear yet, which properties 
of the NP are relevant for computational approaches, and there is still ongoing discussion about the 
appropriate biological endpoint(s) for NP effects.  
Many studies have investigated a variety of endpoints in different in vivo and in vitro systems  
(see e.g. [18–20]). However, oxidative stress is recognized as one of the central mechanisms by which 
NPs might induce toxicity [3,21,22] (even though other in vitro and in vivo endpoints of toxicity may 
deal with different toxic effects). The formation and release of reactive oxygen species (ROS) is 
closely connected to the immune defense system whereby high levels of ROS can lead to a number of 
damaging pathological consequences such as lipid peroxidation, protein damage, deactivation of 
enzymatic activities, and DNA modification and general pro-inflammatory processes. In the normal 
cellular biochemistry there is a balance between free radical formation and the action of an 
antioxidative system. Accordingly, oxidative stress caused by NPs plays a decisive role in cytotoxicity 
and inflammation, eventually leading to the onset of pathophysiological alterations and pathogenesis. 
Consequently we focus on this endpoint in the present model. 
The goal of this paper is to present a concept for dose assessment of nanoparticles using the total 
surface area of NP as a dose metric. This concept is influenced to a large degree by the dose concept 
developed within the field of radiation protection over the last six decades, and it has also the potential 
to complement nano-QSAR models. Accordingly, the presented model takes into account:  
(1) The deposited dose, which is the total deposited NP surface area (SA) per tissue mass or volume 
(m
2
/kg, or m
2
/m
3
 or m
−1
). This SA of the NP has the potential to induce biological effects. Moreover, 
we consider agglomerated NPs as well.  
(2) The equivalent dose, whereby the deposited NP dose is weighted by factors quantifying the 
effects of several other physico-chemical properties of the NPs, such as the specific surface area, 
surface texture, electron band gap interval at the NP surface, surface charge (zeta-potential), NP 
morphology (shape, surface roughness, length-to-width ratio (aspect ratio)), and the dissolution rate.  
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2. Dose Assessment for Ionizing Radiation 
2.1. Exposure to Ionizing Radiation 
Humans can be exposed to ionizing radiation by external irradiation from the environment 
(atmosphere, soil, space,), e.g., from contaminated air or from radioactivity deposited on the ground 
(external exposure), or by internal irradiation from radionuclides taken up into the body, for example 
by inhalation, ingestion or injection (internal exposure). 
For external exposure, only penetrating radiation (gamma radiation, and to a lesser extent high 
energy beta radiation) is relevant for dosimetry because non-penetrating radiation such as alpha 
particles do not reach radiation sensitive cells in the body. However, this non-penetrating radiation is 
very important for dosimetry in the case of internal exposure, especially for those organs where the 
radionuclide accumulates. 
While external exposure can be stopped immediately by shielding or by moving to non-contaminated 
places, internal exposure cannot be stopped until the incorporated radionuclides have been excreted or 
have been eliminated by decay. In the context of this paper nanoparticles taken up into the body may 
be compared to internal radiation exposure. 
2.2. Absorbed Dose of Ionizing Radiation 
The fundamental dose quantity in radiation protection is the absorbed dose, D:  
 
(1) 
with the mean energy    imparted to matter of mass dm with the unit J·kg−1 or the special unit  
gray (Gy). 
In radiation protection, the organ or tissue absorbed dose, DT, which is the mean dose to a target 
organ or tissue T, is often used. For internal exposure DT is expressed by the committed dose to T for a 
defined time period τ (taken to be 50 years for adults). Then: 
 
(2) 
where  is the mean absorbed dose rate in T at time t (Table 1). 
For the calculation of organ absorbed doses for internal exposure, specific information about 
physical and chemical properties of the radionuclide is relevant. These properties include if the 
radionuclide is contained in solid, liquid or gaseous chemical compounds, the particle size in case of 
radionuclides contained in particles, the type and energy of radiation, and the retention time which 
may be characterized by the effective half-life of the radionuclide. In case of inhalation, the “Human 
respiratory tract model for radiological protection” of the ICRP [23], and the “Human alimentary tract 
model for radiological protection” [24] for gastrointestinal exposure are presently used as biokinetic 
models. With these models—together with systemic and excretion models—the numbers of nuclear 
transformations in source regions, body regions where the radionuclide accumulates, can be estimated. 
This information is in turn an input for dosimetric models to calculate absorbed tissue doses.  
  
dm
d
D

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
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Table 1. Dose quantities for radiation and in analogy for nanotoxicology.  
Dose quantities Radiation NP 
Absorbed/ 
deposited dose 
(D):  
The absorbed dose (D) is the mean 
energy  imparted to matter of mass 
dm by ionising radiation, J·kg−1 or Gy:  
 
The deposited dose of NP (DNP) is the total 
deposited surface area (SA) of NP per mass 
of living matter dm, m2/kg:  
 
Dose rate: 
The mean absorbed radiation dose rate in 
T at time t:  
 
The mean absorbed NP dose rate in T at time 
t: 
 
Committed 
tissue dose: 
The quantity of radiation absorbed per 
unit time:  
 
The quantity of absorbed NP dose (uptake) 
per unit time:  
 
Equivalent 
dose: 
The mean absorbed dose from radiation 
R in a tissue or organ T, multiplied by 
the radiation weighting factor wR, J·kg
−1 
or Sv: 
 
Absorbed dose weighted by NP 
property(material) dependent reactivity 
weighting factor(s) wPC,i (i = 1, 2, ….) for 
different physico-chemical properties or 
functional “behaviors” of NP: 
 
Effective dose: 
The tissue-weighted sum of the 
equivalent doses in all specified tissues 
and organs of the body, J·kg−1 or Sv:  
 
The tissue-weighted sum of the equivalent 
doses in all specified tissues and organs of 
the body:  
 
2.3. Equivalent Dose of Ionizing Radiation 
The likelihood of radiation effects depends on the absorbed dose and on the type and energy of  
the radiation. For stochastic effects caused by different types of radiation this is expressed as 
equivalent dose (HT), whereby the quality of radiation is adjusted by dimensionless radiation weighting 
factors [25,26]. These factors were determined by comparing the induced biological damage of the 
radiation to that with an equal dose of gamma or X-rays. X-rays and gamma rays have a weighting 
factor of 1 (1 Gy = 1 Sv), whereas e.g., for the same absorbed dose, alpha particles are considered to 
be 20 times biologically more potent for stochastic effects [25,26]: 
 
(3) 
where DR,T is the absorbed dose from radiation R in a tissue or organ T, and wR the radiation  
weighting factor. 
2.4. Effective Dose of Ionizing Radiation 
There are also different likelihoods for the occurrence of radiation effects/damages in different 
organs and tissues due to different tissue sensitivities [27]. For effective dose calculation, individual 
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organ dose values are multiplied by the respective tissue weighting factor. The sum of all organ 
weighting factors is 1. The present tissue weighting factors are 0.12 each for the red bone-marrow, 
colon, lung, stomach, breast, and the specifically defined so called remainder tissues [26]. 
Furthermore, 0.08 for the gonads and 0.04 each for bladder, esophagus, liver, thyroid and finally 0.01 
each for bone surface, brain, salivary glands, and skin [26]: 
 
(4) 
with tissue weighting factors wT. 
3. Dose Assessment for NPs 
3.1. Exposure to NPs 
Exposure assessment is a major component of dose and thus risk assessment. In case of NP 
exposure, only internal exposure is relevant, since only NPs that have been taken up into the body can 
cause a dose and toxicity. The uptake of NPs can be dermal, by inhalation or ingestion, but also 
through intravenous injection for medical applications. Several exposure scenarios can be considered:  
(i) occupational exposure during NP processing; (ii) exposure to consumers by products containing 
nanomaterial; (iii) exposure by medical applications and (iv) unintentional exposure to the public, e.g., 
by accidental pollution during production processes. The majority of studies aiming to quantify NP 
exposure conditions has been performed in occupational settings, and was focused mainly on 
inhalation exposure. Exposure outside working places are not yet studied; only few modelling studies 
that aim to predict environmental and consumer exposure are available [28,29].  
3.2. Dosimetry for NPs 
3.2.1. Deposited Dose of NP 
As mentioned above, the absorbed dose for ionizing radiation estimates the deposited energy per 
mass of living matter, and the dose rate. In analogy for NP-dose estimation, the deposited dose of NPs 
(DNP) is the total deposited surface area (SA) of NP per mass of living matter (m): 
 
(5) 
The dose rate is one more important variable (or entity) which has to be taken into  
account [30]. Factors affecting the dose rate include the biodegradability of certain NPs. For highly 
biodegradable NP the time for biological response is relatively short, whereas other NPs may not be 
degraded within the body. In addition, fractions of NP, depending on their physico-chemical 
properties, may be retained in the organ where they originally were deposited after intake or they may 
be excreted, whereas others may translocate into the circulation for biodistribution and subsequent 
accumulation in secondary organs or for excretion. In analogy to the absorbed dose in radiation 
dosimetry, the deposited NP dose in a given organ or tissue, DNP,T is adopted. This is the cumulated 
mean dose to a target organ or tissue T. The dose DNP,T is expressed by the committed dose to T for  
a defined time period τ. Then:  
  
T R T
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SAd
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
)(tDNP

Int. J. Environ. Res. Public Health 2014, 11 4032 
 
 
 
(6) 
where is the mean absorbed dose rate in T at time t (Table 1).  
As for radiation dose assessment, biokinetic models for absorbed dose calculations are needed also 
for NP. In analogy, the “Human respiratory tract model for radiological protection” of the ICRP [23] 
can be used for the estimation of deposited doses of inhaled NP in the respiratory tract. The  
multiple-path particle dosimetry (MPPD) model is an advanced modeling software partly based on the 
ICRP model [23]; it considers exhalation and takes into account the deposition and clearance of 
aerosols in the respiratory tract. Particles deposited initially in the respiratory tract during  
inhalation are partly transported to the larynx by mucociliary action out of the lungs and the 
extrathoracic airways and swallowed into the gastrointestinal tract. ICRP has developed a “Human 
alimentary tract model for radiological protection” [24] which could be useful for NP dose calculation 
for the gastrointestinal tract.  
3.2.2. Equivalent Dose of NP and Weighting Factors  
In analogy to radiation weighting factors (wR) for deposited radiation energy, we now propose 
weighting factors (w) which relate to specific quantifiable physico-chemical (PC) properties of the NP. 
Hence, and in contrast to the wR in radiation dosimetry, there will be several weighting factors wPC,i  
(i = 1, 2, ...) for NP which may be constants or functions of NP parameters.  
Accordingly, the equivalent dose HNP,T for each organ or tissue T will be defined similarly to 
Equation (2). In other words, we will use the term “equivalent dose for NP” considering the 
“bioactivity” (or a precursor of equivalent dose) of the NP. The equivalent dose is the product of wPC,i 
multiplied by the deposited dose. Since the weighting factors have been assigned to characteristics of 
the NP which all influence the total absorbed dose, here the product of weighting factors has been 
chosen to enable that each weighting factor separately influences the dose according to the biological 
impact of the respective NP characteristics. Table 1 shows a comparison between the equations for 
ionizing radiation and NPs:  
 (7) 
Introducing this concept of weighting factors w for different PC properties of NPs will allow for the 
estimation of the equivalent dose HNP,T as a function of the deposited NP surface area and of 
equivalent dose comparisons between various engineered NPs and their PC properties. We consider 
that different NP properties are associated with the induction of biological effects. The majority of 
studies which have investigated biological endpoints in nanotoxicology find clear correlations between 
the induction of ROS and nitrogen radicals and our dose metric, namely the deposited NP surface area.  
With this dose concept for deposited NPs using the total deposited surface area as the dose metric,  
a rationale-based and more quantitative ranking of possible effects of NPs in biological tissues will be 
possible. As PC properties characterized by weighting factors we especially consider: (1) the specific 
surface area, (2) the surface textures, (3) the zeta-potential as a measure for surface charge and  
(4) the particle morphology such as the shape and the length-to-width ratio (aspect ratio).  
(5) Furthermore, the band gap energy levels of metal and metal oxide NP are considered where 


0
,, )( dttDD TNPTNP

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
 
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oxidative stress is caused by NPs. The oxidative stress is based on the relationship between the cellular 
redox potential and the band gap energy levels. A further relevant physico-chemical property is (6) the 
particle dissolution/dissociation rate. The proposed wPC,i can be extended and/or modified and adapted 
according to the available data and emerging knowledge. In the present model the reactivity  
of free radicals is considered to be the most relevant biological response for dose estimation. 
Furthermore, functionalized and/or surface modified NPs may represent “new” NPs with their own 
surface area and physico-chemical properties. 
1. Proposal for the first weighting factor wPC,1: The specific surface area (SSA), i.e., the ratio of 
NP surface area to the NP volume, increases with decreasing particle diameter. One single nanoparticle 
can contain atoms/molecules from a few to several orders of magnitude higher numbers of 
atoms/molecules. As a result, a certain fraction of the atoms/molecules is located on the particle 
surface depending on the size, the shape and the physical structure like roughness/smoothness, etc. 
Since it has been shown in many recent papers that the specific surface area is most relevant for the 
induction of oxidative stress, we suggest the first weighting factor wPC,1 to be related to the fraction of 
atoms/molecules on the surface of NPs relative to the total number of atoms/molecules.  
For example, for a spherical NP with the diameter d the volume is π/6 d3, and the spherical surface 
area SA is π d2; hence, the specific surface area SSA becomes: 
 
(8) 
Then the weighting factor is a function of the inverse NP diameter d: 
 
(9) 
In the following we show how the fraction of atoms/molecules on the NP surface NSA per total 
number of atoms/molecules Ntot within the NP will change with NP size dNP and the atomic/molecular 
volumes Vmol of a number of relevant metal and metal oxide NPs. This fraction will be proportional to 
the weighting factor affecting biological effects: 
 
(10) 
This ratio is shown for gold (atom diameter 0.29 nm) and silver (atom diameter 0.32 nm) in  
Figure 1a. Since the gold atoms are smaller than the silver atoms, the fraction of gold atoms on the 
surface is slightly lower compared to that of the silver atoms. 
Similarly, crystallographic data on the molecular dimensions can be used to estimate the number of 
various metal oxides molecules on the surface as well as within the NP lattice; this is shown for 
spherically shaped NPs of titanium dioxide, gamma Fe2O3 hematite, Fe3O4 magnetite and monoclinic 
CuO in Figure 1b. Since the tetrahedral structure of the TiO2 molecules is smallest, their fraction of 
atoms on the surface relative to the total number of TiO2 molecules in the NP is smaller than those of 
the other metal oxide molecules; vice versa the surface fraction of Fe3O4 magnetite is highest since 
these are the largest of the selected metal oxide molecules. 
d
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While this wPC,1 is declining rapidly with increasing size of the NP (see Figure 1a,b), wPC,1 behaves 
different for agglomerates of primary nano-scaled particles. Agglomerates coagulate, e.g. due to weak 
forces like the van-der-Waals force or magnetic forces in case of magnetic nanoparticles, such that 
their contact points are infinitesimally small [31]. As a result the surface area SAagg of an agglomerate 
is the sum of the surface areas of all primary particles SApp within an agglomerated particle; similarly 
the volume of the aggregate is the sum of all volumes of the primary particles. If all primary particles 
are of the same size then they all have the same surface area SApp and the same volume Vpp or mass 
and, hence, the same specific surface area SSApp. Applying this to an agglomerated particle of n 
identical primary particles, the agglomerated particle has the same specific surface area SSApp as the 
primary particles independent of the number of primary particles within an agglomerated particle: 
        
      
      
   
    
   
         (11) 
Hence wPC,1 becomes a constant: 
wPC,1 = f (SSApp) = cagg for agglomerates of same-sized primary particles (12) 
where cagg is a constant which differs for different sizes of primary particles.  
If the primary particles are not all of the same size but show a size distribution, then their 
agglomerates may differ in their specific surface area. Yet when considering a large enough number of 
agglomerates, they will have a specific surface area SSAagg which is equal to the average of the specific 
surface area of the primary particles and this is independent of the actual size of the 
agglomerate [32].  
Figure 1. Weighting factor 1 in arbitrary units which is proportional to SSA—i.e., the ratio 
of atoms/molecules at the NP surface over the total number of atoms/molecules: (a) gold 
(Au) and silver (Ag) NP, (b) TiO2, CuO, Fe2O3, and Fe3O4, (c) for agglomerated NPs with 
2, 5 and 10 nm primary particle size, (d) spherical and agglomerated TiO2 with different 
primary sizes. Panels (c) and (d) show that wPC,1 is constant for different sizes of 
agglomerates but changes with the SSA of primary particles. 
 
(a) 
  
ppSSA
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Figure 1. Cont. 
 
(b) 
 
(c) 
 
(d) 
Hence, for agglomerates containing a large enough number of primary particles with a mean 
 wPC,1 is also a constant c’agg depending solely on the mean of the primary particles 
(Figure 1c,d) 
ppSSA ppSSA
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wPC,1 = f ( ) = c’agg for agglomerates (13) 
2. Proposal for the second weighting factor wPC,2: wPC,2 represents an arbitrary weighting factor 
for the surface texture. For spherical NPs with smooth surfaces wPC,2 is set to unity wPC,2 = 1 while 
wPC,2 becomes wPC,2 > 1 for irregularly shaped NPs with sharp edges and ridges and a rough surface. 
This surface roughness relates to the fact that atoms/molecules on the rough surface of NP are less 
integrated into the NP lattice and may be “unsaturated”, such that they are more prone to electron 
transfer than the inner atoms/molecules of the NPs leading to oxidative stress reaction in biological 
systems. In addition, their relative number to the total number increases due to the increasing surface 
area; hence, free radical production may increase and/or these atoms/molecules may change their 
stoichiometry and/or they may even leave the NP surface such that the remaining NP surface texture 
may increase in surface reactivity. 
For spherical NPs curvature increases drastically with decreasing size and is proportional to the 
inverse of the diameter d of the NP as discussed above. In analogy of the Young-Laplace equation 
which relates pressure p on the surface of a liquid sphere to surface tension σ and the inverse of  
the diameter: 
p = 4 σ/d (14) 
we can introduce a surface module σ’ which describes the probability of atoms/molecules at the 
surface to either alter their electron shell or change their molecular composition (which also leads to 
altered electron shells) or even escape the surface. The probability will be greater than the probability 
σ0‘ for atoms/molecules inside the NP. In the absence of precise data we propose for wPC,2: 
wPC,2~(σ‘/σ0‘)/d with 1 < σ‘/σ0‘ < 10 (15) 
This is shown in Figure 2 for a NP with smooth surface versus a NP with a 10-times  
increased roughness. 
3. Proposal for the third weighting factor wPC,3: The zeta potential (ZP) is the net electric potential 
formed by the charged groups of molecules of the NP surface and the surrounding medium. The ZP 
depends strongly on the pH of the medium: Commonly, absorption of proteins onto the NP surface 
may shift the ZP towards neutral ZP. For a quantitative estimate of ZP we use data recently  
published [33,34] and plot the relative neutrophil influx (NNI) in rat lungs versus the ZP (mV) of NPs 
of different materials which had been instilled 24 hours prior to broncho-alveolar lavage and 
subsequent NNI and ZP measurements. 
The neutrophil influx is normalized to baseline values of neutrophil influx observed with  
non-reactive NP and without NP. The observed increase of NNI was fitted by a linear trend [33,34] 
(Figure 3): 
NNI = 1.12 × ZP − 6.23 for ZP > 6 mV  
Therefore, we propose for the zeta potential ZP a weighting factor wPC,3 (arbitrary value): 
wPC,3 = max{1, 1.12 × ZP − 6.23} (16) 
  
ppSSA
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Figure 2. Weighting factor 2 (wPC,2) is proportional to the surface texture of NPs given as 
relative roughness module: spherical NPs with smooth surface wPC,2 = 1 while wPC,2 is set 
to 10 for irregularly shaped NPs with sharp edges and ridges and a rough surface. 
 
Figure 3. Weighting factor 3 (wPC,3) is depending on the zeta potential: The weighting 
factor is proportional to the relative PMN influx and increases according to equation 16. 
However, for a low zeta potential, it is not less than 1 [30,33]. 
 
4. Proposal for the fourth weighting factor wPC,4: The wPC,4 is a weighting factor for the particle 
morphology. NPs may not only be spherically shaped, but elongated with a very high aspect ratio (ratio 
of NP length to NP diameter) like biopersistent and long carbon nanotubes (CNTs). We gather from 
the existing literature on CNTs and biopersistent asbestos fibers that the induction of free radicals and 
hence oxidative stress is caused by frustrated phagocytosis of lung macrophages ([34] and others) 
which cannot completely phagocytize CNTs with a length of more than 15 µm. This phenomenon has 
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been shown in the literature and represents therefore a clear connection to the development of 
mesothelioma and subsequent death as shown by asbestos workers in the past. As an example we set 
normal phagocytosis without enhanced induction of ROS to unity and compare this to a high factor of 
500 for enhanced frustrated phagocytosis associated with massive ROS induction and the potential for 
carcinogenicity. Due to the carcinogenic risk of developing mesothelioma we propose a high value for 
the weighting factor wPC,4 (Figure 4): 
wPC,4 = 1 for NNI at normal phagocytosis 
wPC,4 = 500 for NNI at frustrated phagocytosis 
(17) 
Figure 4. Weighting factor 4 (wPC,4) for particle morphology is proportional to frustrated 
phagocytosis of intratracheally instilled biopersistent and long carbon nanotubes (CNT): 
for normal phagocytosis wPC,4 is set to 1 while the wPC,4 is set to 500 for enhanced 
frustrated phagocytosis of CNT longer than 15 μm. We consider the risk of cancer 
induction and the risk of subsequent death as a most threatening event such that we chose  
a factor of 500. 
 
 
5. Proposal for the fifth weighting factor wPC,5: Burello and Worth [9] developed a theoretical 
predictive model for oxidative stress caused by metal and metal oxide NPs, based on the relationship 
between the cellular redox potential to band gap energy levels of metal and metal oxides. The authors 
suggest that these NPs with a diameter larger than 20–30 nm, whose band gap energy (Ec) falls within 
the range of cellular redox potentials (−4.12 to −4.84 eV), are able to cause oxidative stress in 
biological systems. In a comprehensive study including in vitro, in vivo and multiparametric high 
throughput screening, Zhang et al. [35] confirmed this theoretical model for several metal and metal 
oxide NP materials. Therefore we propose a weighting factor for band gap energy levels (wPC,5). There 
are only very limited data which suggest that only in the selected band gap interval ROS formation 
occurs to a significant extent. From data cited in the literature we extrapolated a factor of 10 of the 
increase of weighting factor 5 as a plausible example. For NPs showing a band gap energy in the range 
of 4.1–4.8 eV we set wPC,5 = 10, otherwise it is set to wPC,5 = 1 (Figure 5): 
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wPC,5 = 10 for NP atoms/molecules within band gap interval of 4.1–4.8 eV 
wPC,5 = 1 for NP atoms/molecules outside the above band gap interval 
(18) 
Figure 5. Weighting factor 5 (wPC,5) for the band gap energy levels of metal and metal 
oxides for NP larger than 20–30 nm: If NP is showing a band gap energy in the range of 
4.1–4.8 eV, the wPC,5 is set to 10 otherwise it is 1. 
 
6. Proposal for the sixth weighting factor wPC,6: wPC,6 is proposed to be a function of the 
dissolution/dissociation rate of NPd which has been shown to be proportional to the specific surface 
area SSA of most NP [36–38]. In fact, SSA is inversely proportional to the NP diameter d (Equation (1)) 
and proportional to the dissolution rate constant k; the latter is NP-material dependent and also 
depending on the physico-chemical properties of the cytosolic or body-fluidic solvents. According to 
earlier reports [39] the fractional loss of NP mass mNP over time t is:  
 
(19) 
and the weighting factor wPC,6 is proportional to the inverse of the diameter, the dissolution rate 
constant of the NP in the biological fluid and time t: 
 
(20) 
Changes of the fractional rate over time are shown in Figure 6 for NPs of different sizes and 
different dissolution rate constants.  
  
d
kt
tSSAk
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m
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
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Figure 6. Weighting factor 6 (wPC,6) is a function of the dissolution rate of the NP. Panel a: 
fractional mass loss of differently soluble NPs over NP diameters ranging from 5 to 250 nm; 
Panels b–d give the fractional NP mass losses over time for different NP sizes of virtually 
insoluble (b), moderately soluble (c) and highly soluble NPs (d). 
 
(a) 
 
(b) 
 
(c) 
  
Int. J. Environ. Res. Public Health 2014, 11 4041 
 
 
Figure 6. Cont. 
 
(d) 
3.2.3. Consequences for Equivalent Dose of NP 
To summarize the above mentioned model, the equivalent dose of NP (HNP,T) is calculated by 
multiplying the deposited dose to the organ or tissue (DNP,T) with the nanomaterial specific weighting 
factors wPC,i. These factors consider the physico-chemical properties of specific NPs. The product of 
weighting factors wPC,i is proportional to the observed biological effect, of organ or tissue T for the 
same deposited NP dose. For weighting factors wPC,1, wPC,3, wPC,5, and wPC,6 we used the equations 
provided in section “Equivalent dose of NP and weighting factors” and the corresponding figures. Due 
to the lack of in vivo and in vitro data regarding wPC,2 and wPC,4 we have suggested sets of data and 
provided their plausibility in section “Equivalent dose of NP and weighting factors”. These data were 
used to demonstrate how the deposited dose can be influenced by the physico-chemical properties of 
NP leading to the equivalent dose (HNP,T).  
Figure 7 shows the comparison of equivalent doses of different metal and metal oxide NPs being 
proportional to the product of the various wPC,i. For example 5 nm Ag-NP has a substantially higher 
HNP,T than TiO2 because the wPC,6 of Ag-NP is 1,000-fold higher according to its very high dissolution 
rate constant and its very small diameter. CuO and Ag-NP are both rather soluble and the released ions 
were shown to induce oxidative stress or are bactericidal, respectively. Therefore, the product of the 
wPC,i—which is proportional to the equivalent dose—of both CuO and Ag-NP is determined by their 
high dissolution rate constants. It is interesting to see the differences of the HNP,T of hematite and 
magnetite form of Fe2O3. Again, the product of the wPC,i is determined by their different dissolution 
rate constants and sizes. As shown in Figure 7a, the equivalent dose for Au-NP is lowest since the 
values of wPC,2–6 are minimal, while other NP—depending on their physico-chemical properties—show 
higher values for one of wPC,i. 
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Figure 7. Comparison of the “equivalent dose” described by the product of all wPC,i for 
different NPs. The tables specify the wPC,i for each NP of 5, 50 and 100 nm diameter: (a) 
different metal and metal oxide NPs, and (b) for SWCNTs and MWCNTs. Note that in (b) 
Fe-ions of the dissolving Fe-oxide NPs play a key role in the Fenton reaction seen as a 
main source of ROS induction in biological systems, leading to oxidative stress. The tables 
indicate the calculation of the “equivalent dose”. For wPC,3 we either presumed a zeta 
potential below 6 mV leading to a wPC,3 value of 1 or a zeta potential of >15 mV leading to 
a wPC,3 value set to 10 in the absence of detailed information. 
 
(a) 
Particles 
wPC,1 * 
(SSA) 
wPC,2 
(ST) 
wPC,3 
(ZP) 
wPC,4 
(M) 
wPC,5 
(BG) 
wPC,6 
(DR) 
“Equivalent dose” per unit 
of deposited NP surface area 
5 nm        
Au-NP 0.28 1 1 1 1 1 0.28 
Ag-NP 0.30 1 1 1 1 1000 303.1 
TiO2-NP 0.25 3 10 1 1 1 7.5 
CuO-NP 0.20 1 1 1 1 1000 195.6 
Fe2O3 hematite NP 0.62 3 10 1 1 100 1,865.0 
Fe3O4 magnetite NP 0.89 3 10 1 1 10 266.3 
50 nm 
       Au-NP 0.03 1 1 1 1 1 0.03 
Ag-NP 0.03 1 1 1 10 100 34.2 
TiO2-NP 0.03 3 10 1 10 1 7.5 
CuO-NP 0.02 1 1 1 10 100 19.6 
Fe2O3 hematite NP 0.08 3 10 1 10 10 225.9 
Fe3O4 magnetite NP 0.12 3 10 1 10 1 37.2 
100 nm 
       Au-NP 0.02 1 1 1 1 1 0.02 
Ag-NP 0.02 1 1 1 10 50 8.6 
TiO2-NP 0.01 3 10 1 10 1 3.8 
CuO-NP 0.01 1 1 1 10 50 4.9 
Fe2O3 hematite NP 0.04 3 10 1 10 5 57.1 
Fe3O4 magnetite NP 0.06 3 10 1 10 1 18.9 
* For definition of the wPC,i see the text in section “Equivalent dose of NP and weighting factors” and  
Figure 1. SSA: specific surface area; ST: surface textures; ZT: zeta-potential; M: morphology; BG: bend gap 
energy level; DR: dissolution rate.  
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(b) 
CNT wPC,1 wPC,2 wPC,3 wPC,4 wPC,5 wPC,6 
“Equivalent dose” 
(unit of deposited 
NP surface area) 
SWCNT (d = 5 nm, length 5 µm) 1 10 1 1 1 1 10 
SWCNT (d = 5 nm, length 15 µm) 1 10 1 500 1 1 5,000 
MWCNT (d = 50 nm, length 15 µm) * 0.02 10 1 500 1 1 100 
* wPC,1: MWCNT with 50 layers. 
In case of SWCNTs, the ratio of the surface atoms to the total = 1 since all atoms are on the surface. 
The wPC,2 namely the surface texture is set to 10 since it is known that the form of the CNT  
and the length are relevant for the induction of biological effects. Moreover, it is known that the 
length-to-width ratio (aspect ratio) of the CNT is related to the “frustrated phagocytosis”. Therefore 
wPC,4 is the main weighting factor which is set to 500 for >15 µm SWCNTs (Figure 7b), since we 
consider the development of mesothelioma including subsequent death (as has been proven by many 
asbestos workers) as the highest risk. For MWCNTs the wPC,1 is different, depending of the number of 
layers and the correspondingly smaller ratio of surface atoms to total atoms, therefore the magnitude of 
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the equivalent dose is 50-fold lower in this case. In summary, the application of wPC,i allows the 
comparison of the product of all weighting factors which is proportional to the equivalent dose of 
specific NP, and allows also a quantitative ranking or categorization of specific NPs. Figure 7 provides a 
first attempt how the equivalent NP dose can be ranked and it shows the huge differences between the 
various NP due to different physico-chemical properties.  
3.2.4. Effective Dose 
Only a few studies have investigated the sensitivity of organs, tissues and cells to NP-exposure (for 
review see [40]. In a recent in vitro study Sohaebuddin et al. [41] have shown that different cell types 
react with different sensitivity to the same NP exposure by expressing cell specific responses. 
However there are not enough adequate studies performed yet, to rank the sensitivity of organs, tissues 
or cells, whereby the sensitivity has to be compared with the same NP-dose under the same conditions. 
If the deposited dose and the equivalent dose are known, cell or tissue weighting factors might be 
introduced as was done for dose calculation of ionizing radiation. The relative biological effectiveness 
(RBE) or the biologically effective dose (BED; e.g., [21] can then be calculated as a function of the 
quality of the NP-exposure and the tissue/organ/cell. It has to be pointed out, that for radiation, tissue 
weighting factors are based on the concept of stochastic no-threshold radiation effects by linear 
extrapolation of available data of high radiation doses. For nanomaterials no data are available neither 
for long term exposure nor about sensitivity of organs and tissues. Therefore at present we cannot 
propose any tissue weighting factors, but it is suggested to identify sensitivities of organs, tissues, and 
cells, and then to apply it in analogy to radiation dosimetry:  
 (21) 
4. Conclusions 
In the present paper we introduce a model for dose comparisons in analogy to the ionizing radiation 
dose model. The NP dose model includes the deposited dose (D) as the total deposited NP surface area 
per tissue mass in analogy to the absorbed radiation energy in biological tissue, the dose rate (uptake 
over time) and the biokinetics. The equivalent dose (H) takes into account the physico-chemical 
properties of different NPs. These physico-chemical properties are currently quantifiable and are 
included in the concept as NP-specific weighting factors. Furthermore, at present there are not enough 
data available to estimate the effective dose (E, weighted by the sensitivity of the biological material; 
tissue, organ, and cell), however we suggest to use specific organ/tissue/cell weighting factors when 
data will be available. The calculated equivalent doses for the different NPs in this paper show relative 
differences. Their actual values have to be determined in dedicated experimental investigations such as 
high throughput (HTP) in silico and in vitro assays. To progress systematically on the determination of 
weighting factors other relevant biological endpoint(s) have to be considered and tested. As it is known 
for ionizing radiation, data from a battery of endpoints indicate the biological effectiveness of the 
damaging agent. Similar approaches, by using modern HTP techniques, will allow identification of 
absolute numbers for weighting factors and differences on NP-equivalent doses.  
 
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In summary, experience from radiobiology in generating a dose concept for deposited NPs seems to 
be very valuable. Thus, the implementation of deposited, equivalent and effective doses as well as dose 
rate according to the established radiation dose model could initiate further research and facilitate the 
understanding of NP-dose and related effects. The implementation of weighting factors based on 
different physico-chemical properties of specific NPs is an initial and useful tool to compare their 
equivalent doses. The presented NP dose model is meant to be a start for a NP dose assessment which 
needs further development.  
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